Boehringer Ingelheim Expands 'Detect SOS' Mission Globally to Address UACR Testing Gap That Leaves Millions Vulnerable to Undetected Heart, Kidney Risks
September 22, 2026
September 22, 2026
INGELHEIM AM RHEIN, Germany, Sept. 22 (TNSrep) -- Boehringer Ingelheim, a pharmaceutical company, issued the following news release:
* * *
Boehringer Ingelheim expands 'Detect the SOS' mission globally to address the uACR testing gap that leaves millions vulnerable to undetected heart and kidney risks
Ingelheim, Germany, Mon, 21/09/2026
* Millions of adults with hypertension, type 2 diabetes, or both remain vulnerable to serious hidd . . .
* * *
Boehringer Ingelheim expands 'Detect the SOS' mission globally to address the uACR testing gap that leaves millions vulnerable to undetected heart and kidney risks
Ingelheim, Germany, Mon, 21/09/2026
* Millions of adults with hypertension, type 2 diabetes, or both remain vulnerable to serious hidd . . .
